IRS1 and Insulin resistance: AC6 improved insulin sensitivity through the enhancement of insulin action on insulin receptor substrate-1 (IRS-1) associated phosphoinositide 3-kinase (PI3-kinase) and glucose transporter type 4 (GLUT4) activities in the muscles of animals exhibiting insulin resistance [59].